Correction to: Current Treatment Options in Oncology (2022) 23:1503-1521
The original version of this article, unfortunately, contained mistakes.
The author list was arranged incorrectly. The correct sequence of authors is presented below:
Jingqin Zhong, MD
Wangjun Yan, PhD
Chunmeng Wang, PhD
Wanlin Liu, MD
Xinyi Lin, MD
Zijian Zou, MD
Wei Sun, PhD*
Yong Chen, PhD*
*Email: Yong Chen, chenyong@fudan.edu.cn; Wei Sun, wsun14@fudan.edu.cn
Acknowledgements
Jingqin Zhong would like to extend his sincere gratitude to his supervisor, Yong Chen, for his instructive advice and useful suggestions on Jingqin Zhong's thesis. He is deeply grateful of his help in the completion of this thesis. High tribute shall be paid to Wei Sun, whose profound knowledge of English triggers Jingqin Zhong's love for research. He is also deeply indebted to all the other contributors. Finally, Jingqin Zhong is indebted to his parents for their continuous support and encouragement.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of Interest
This work was supported by Shanghai Science and Technology Development Funds (19411951700), the Lingang Laboratory (Grant No. LG-QS-202205-11), and the national natural science foundation of China (81802636).
JZ wrote and edited this manuscript and created tables and figure. JZ, ZZ, WS, WY, CW, WL, XL, and YC reviewed and revised the manuscript. WS and YC provided direction and guidance throughout the preparation of the manuscript. All authors read and approved the final manuscript.
The original article has been corrected.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The online version of the original article can be found at https://doi.org/10.1007/s11864-022-01006-7.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Zhong, J., Yan, W., Wang, C. et al. Correction to: BRAF Inhibitor Resistance in Meslanoma: Mechanisms and Alternative Therapeutic Strategies. Curr. Treat. Options in Oncol. 23, 1877–1878 (2022). https://doi.org/10.1007/s11864-022-01038-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11864-022-01038-z